Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)
Breast Cancer Res Treat. 2022 Jun;193(3):565.
doi: 10.1007/s10549-022-06613-4.
1 NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA. charles.geyer@nsabp.org.
2 UPMC Hillman Cancer Center, Pittsburgh, PA, USA. charles.geyer@nsabp.org.
3 NRG Oncology, Nova Tower 2, Two Allegheny Center, Suite 1245, Pittsburgh, PA, 15212, USA.
4 Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
5 UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
6 Department of Oncology, Magee Womens Hospital, Pittsburgh, PA, USA.
7 Department of Surgery, Breast Cancer Research Group (GRCS), Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, QC, Canada.
8 Kaiser Permenente Northern California, Vallejo, CA, USA.
9 Department of Medical Oncology, Onoclogy/Hematology Care Clinical Trials, Cincinnati, OH, USA.
10 Department of Research and Evaluation - Clinical Trials -Oncology, Kaiser Permanente Southern California, San Diego, CA, USA.
11 Centre des Maladies du Sein du CHU de Québec - Université Laval, Québec, QC, Canada.
12 Department of Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada.
13 Norton Cancer Institute, Louisville, KY, USA.
14 Department of Medical Oncology, CCOP, Ozark Health Ventures LLC-Cancer Research for the Ozarks, Springfield, MO, USA.
15 Cancer Medicine Department of Hematology/Oncology, Puerto Rico NCORP/UPR Comprehensive Cancer Center, San Juan, PR, USA.
16 Department of Surgery, Allegheny Health Network/Allegheny General Hospital, Pittsburgh, PA, USA.
17 Department of Research Development, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, MedStar Health, Washington, DC, USA.
18 Department of Surgery, Orlando Health UF Health Cancer Center, Orlando, FL, USA.